EX-23.1 8 nlnk-20180726xs3xex231.htm EXHIBIT 23.1 Exhibit
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
The Board of Directors
NewLink Genetics Corporation:

We consent to the use of our report with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
Des Moines, Iowa
July 26, 2018